An early Entrepreneurial Accelerator Program portfolio company, Oleolive continues to find success in the nutrition market
Applied Food Sciences, Oleolive partner to launch patented olive polyphenol ingredient
Applied Food Sciences, Inc. (AFS) announced an exclusive partnership with Shreveport, Louisiana-based Oleolive, Inc. to bring a novel, high-quality olive extract ingredient, Oligen, to the global nutrition market.
This strategic alliance combines AFS’ expertise in market development and formulation with Oleolive’s proprietary and patented extraction technology to provide a premium, USA-based solution for brands seeking to capitalize on the growing demand for science-backed longevity and mobility ingredients.
Oligen is the initial ingredient to emerge from this exclusive partnership, designed to capture the powerful benefits of olive polyphenols in a highly concentrated and bioavailable format.
“Extra virgin olive oil has long been celebrated as a symbol of vitality and health, yet the key actives, oleocanthal and oleacein, are present only in trace amounts,” said Kiley Grant, CEO at Oleolive. “Oligen unlocks these rare compounds at scale, delivering purity, consistency, and performance never before possible…”
Partnering with Applied Food Sciences ensures we launch this ingredient with the strength of both innovation and market expertise, guided by our shared commitment to quality and a vision of making these unique polyphenols more accessible than ever before.
“We are incredibly excited to partner with Oleolive to introduce Oligen to the nutrition space…” said Chris Fields, Chief Science Officer at Applied Food Sciences.
What sets this partnership and ingredient apart is the patented process behind it, which allows us to deliver a superior product with a focus on quality, purity, and most importantly, efficacy. With its USA-based processing, we can ensure a stable, secure, and reliable supply chain, which enables AFS to confidently deliver on the growing demand in today’s supply-sensitive market.
The leadership team of Shreveport-based Oleolive. Left to right: David Coleman, PhD, Chief Science Officer; Alana Gray, PhD, Chief Operating Officer; Kiley Grant, Chief Executive Officer; Jim Cardelli, PhD, Chief Technology Officer.
The patented processing technology focuses on standardizing Oligen to two key active polyphenolic compounds, oleocanthal and oleacein, which contribute to a host of functional benefits. As effective COX-2 inhibitors, Oligen is ideal for promoting joint health by supporting a healthy inflammatory response.
Oleocanthal and oleacein also have benefits for heart health and longevity, making Oligen an attractive ingredient for healthy aging formulas. With its fast onset and high bioavailability, Oligen has an advantage over other botanical ingredients as it delivers rapid results without requiring expensive enhancers or specialty delivery systems.
BRF and EAP congratulate Oleolive on global partnership
“Congratulations to the team at Oleolive. They have been a wonderful example of taking a technology, and an idea, and turning it into a successful business right here in Northwest Louisiana,” said EAP Executive Director Dave Smith. “We wish them continued success.”
Learn more about Oligen here, and visit Oleolive’s website to learn more about this Shreveport-based company.
Shreveport has long been a healthcare hub for our region. It’s exciting to now see our area have an impact on the health of others across the world through the developments being made by Oleolive.
